$6.44
-0.05-0.77%
Last update: Oct 23, 4:00 PM
Bausch Health Companies Inc (BHC) Stock Price, Quote, News & History
BHCNYSE
Bausch + Lomb stock drops 10% following sudden CEO departure, despite raising full-year 2026 EBITDA guidance.
You can purchase shares of Bausch Health Companies (NYSE:BHC) through any online brokerage.
Other companies in Bausch Health Companies’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Bausch Health Companies has a consensus price target of $7.14.
The stock price for Bausch Health Companies (NYSE: BHC) is $6.44 last updated October 23, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Bausch Health Companies.
Bausch Health Companies does not have any upcoming earnings scheduled.
There is no upcoming split for Bausch Health Companies.
Bausch Health Companies is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in...
